Principal Financial Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $288K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.72M | Buy |
|
|||||
|
2024
Q4 | $4.15M | Buy |
|
|||||
|
2024
Q3 | $3.97M | Buy |
|
|||||
|
2024
Q2 | $591K | Sell |
|
|||||
|
2024
Q1 | $701K | Sell |
|
|||||
|
2023
Q4 | $565K | Sell |
|
|||||
|
2023
Q3 | $515K | Buy |
|
|||||
|
2023
Q2 | $246K | Sell |
|
|||||
|
2023
Q1 | $225K | Buy |
|
|||||
|
2022
Q4 | $226K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $207K | Buy |
|